Abcixirel 10mg Injection

Avoid using the Abcixirel 10mg injection if you’re allergic to Abciximab or any of its constituents. Refrain from its use if you’re experiencing active internal bleeding, recent (within six weeks) clinically significant gastrointestinal or genitourinary bleeding, or if you’ve had a cerebrovascular accident (CVA) within the past two years, especially if it resulted in significant lasting neurological impairment. Additionally, this injection should not be used if you have a bleeding tendency, have taken oral anticoagulants in the last seven days without reaching prothrombin time within 1.2 times the control, or have thrombocytopenia with a platelet count below 100,000 cells/μL.
Furthermore, avoid this product if you’ve undergone major surgery or trauma in the past six weeks, have an intracranial neoplasm, arteriovenous malformation, or aneurysm, suffer from severe uncontrolled hypertension, have a documented history or presumed diagnosis of vasculitis, or have received intravenous dextran before percutaneous coronary intervention or plan to use it during such an intervention. It’s important to note that the safety and effectiveness of this medication have not been studied in children.